Telix Pharmaceuticals Limited (ASX: TLX)
Australia flag Australia · Delayed Price · Currency is AUD
18.15
+2.41 (15.31%)
May 31, 2024, 2:10 AM EDT

Telix Pharmaceuticals Income Statement

Millions AUD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2013
Revenue
496.66160.17.65.213.49
Upgrade
Revenue Growth (YoY)
210.23%2007.64%45.71%49.58%1685.88%
Upgrade
Cost of Revenue
188.16130.7637.3622.0915.36
Upgrade
Gross Profit
308.529.34-29.77-16.88-11.88
Upgrade
Selling, General & Admin
133.8544.6617.359.297.22
Upgrade
Research & Development
128.8457.8634.1423.0921.16
Upgrade
Other Operating Expenses
-29.343.0923.552.9611.44
Upgrade
Operating Expenses
269.27102.5251.4832.3828.38
Upgrade
Operating Income
17.03-73.18-81.25-49.25-40.26
Upgrade
Interest Income
1.0200.160.070.1
Upgrade
Interest Expense
13.140.410.191.182.41
Upgrade
Other Expense / Income
1.8225.0417.779.890.25
Upgrade
Pretax Income
3.09-98.62-99.04-60.25-42.82
Upgrade
Income Tax
-2.125.46-18.53-15.37-14.95
Upgrade
Net Income
5.21-104.08-80.51-44.89-27.87
Upgrade
Shares Outstanding (Basic)
319311282257233
Upgrade
Shares Outstanding (Diluted)
324311282257233
Upgrade
Shares Change
4.21%10.08%9.69%10.21%15.49%
Upgrade
EPS (Basic)
0.02-0.34-0.29-0.17-0.12
Upgrade
EPS (Diluted)
0.02-0.34-0.29-0.17-0.12
Upgrade
Free Cash Flow
13.09-77.83-60.671.64-23.8
Upgrade
Free Cash Flow Per Share
0.04-0.25-0.210.01-0.10
Upgrade
Gross Margin
62.12%18.32%-391.85%-323.75%-340.75%
Upgrade
Operating Margin
3.43%-45.71%-1069.60%-944.81%-1155.12%
Upgrade
Profit Margin
1.05%-65.01%-1059.90%-861.06%-799.63%
Upgrade
Free Cash Flow Margin
2.64%-48.62%-798.67%31.42%-682.96%
Upgrade
Effective Tax Rate
-68.80%----
Upgrade
EBITDA
23.77-67.8-76.07-44.37-36.02
Upgrade
EBITDA Margin
4.79%-42.35%-1001.49%-851.16%-1033.57%
Upgrade
Depreciation & Amortization
6.925.385.174.884.24
Upgrade
EBIT
16.85-73.18-81.25-49.25-40.26
Upgrade
EBIT Margin
3.39%-45.71%-1069.60%-944.81%-1155.12%
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.